Financials

News Ideas Discussions Technicals Seasonals

ALBIO fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Biosynex SA engages in the provision of development, production, and distribution of Rapid Diagnostics Tests (RDTs) for pathologies. It operates through the Professional and Consumer segments. The Professional segment allows proper medical management of the patients. The Consumer segment permits the general public to self-monitor. The company was founded by Larry Abensur, Thomas Lamy, and Thierry Paper on March 15, 2005 and is headquartered in Illkirch-Graffenstaden, France.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

ALBIO has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company